Fine-Tuning of the Neuropeptide Y1 G Protein-Coupled Receptor by the Tryptophan <sup>6.48</sup> “Toggle Switch”

G protein-coupled receptors (GPCRs) transduce extracellular signals into the cell through binding and activation of intracellular effector proteins. Highly conserved residues such as tryptophan W<sup>6.48</sup> of transmembrane helix 6 can play a role in GPCR activation, where W<sup>6.48</sup> acts as a microswitch, changing its rotameric state depending on whether the receptor is bound to an agonist or antagonist. However, its exact role is not entirely clear. Here we investigate the role of W<sup>6.48</sup> in the neuropeptide Y1 receptor (Y1R). Via NMR experiment and molecular dynamics simulations, we find that on the one hand, W<sup>6.48</sup> exhibits multiple rotameric conformations, where simulations indicate that these are coupled to backbone structure. On the other hand, mutation of W<sup>6.48</sup> to alanine does not prevent G-protein signaling, and agonist vs antagonist bound Y1R exhibits the same W<sup>6.48</sup> rotameric state, calling into question whether its core function is to regulate Y1R activation. Further investigation indicates that the W<sup>6.48</sup> rotameric state restricts microstates accessible by Y1R and impacts backbone dynamics. Using principal component analysis of multiple MD trajectories, we determine the structural similarity between Y1R for the various apo, NPY, NPY/Gi, and antagonist-bound conformational states. We propose a role for W<sup>6.48</sup> in regulating Y1R binding, in which rotameric changes for W<sup>6.48</sup> influence ligand binding by favoring backbone structures in apo Y1R that are similar to those observed for the active protein. Mutation of W<sup>6.48</sup> then does not eliminate these structures but reduces their prevalence. Therefore, W<sup>6.48</sup> provides "fine-tuning" of Y1R signaling; mutation of the 6.48 position leaves Y1R active but "detuned" such that signaling is still possible, but proper functioning is inhibited by a decrease in ligand binding rate.

Authors

Institutions

Publication Details

Journal
Journal of the American Chemical Society
Published
2025-12-19
DOI
https://doi.org/10.1021/jacs.5c07143
Primary Topic
Receptor Mechanisms and Signaling
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Fine-Tuning of the Neuropeptide Y1 G Protein-Coupled Receptor by the Tryptophan 6.48 “Toggle Switch”

Anette Kaiser, Albert A. Smith, Karl Leitner, Alexander Vogel et al.
Journal of the American Chemical Society
Receptor Mechanisms and Signaling
article

Fine-Tuning of the Neuropeptide Y1 G Protein-Coupled Receptor by the Tryptophan 6.48 “Toggle Switch”

Anette Kaiser, Albert A. Smith, Karl Leitner, Alexander Vogel, Daniel Huster, Maik Pankonin, Peter W. Hildebrand, Matthias Voitel
article en

Abstract

G protein-coupled receptors (GPCRs) transduce extracellular signals into the cell through binding and activation of intracellular effector proteins. Highly conserved residues such as tryptophan W<sup>6.48</sup> of transmembrane helix 6 can play a role in GPCR activation, where W<sup>6.48</sup> acts as a microswitch, changing its rotameric state depending on whether the receptor is bound to an agonist or antagonist. However, its exact role is not entirely clear. Here we investigate the role of W<sup>6.48</sup> in the neuropeptide Y1 receptor (Y1R). Via NMR experiment and molecular dynamics simulations, we find that on the one hand, W<sup>6.48</sup> exhibits multiple rotameric conformations, where simulations indicate that these are coupled to backbone structure. On the other hand, mutation of W<sup>6.48</sup> to alanine does not prevent G-protein signaling, and agonist vs antagonist bound Y1R exhibits the same W<sup>6.48</sup> rotameric state, calling into question whether its core function is to regulate Y1R activation. Further investigation indicates that the W<sup>6.48</sup> rotameric state restricts microstates accessible by Y1R and impacts backbone dynamics. Using principal component analysis of multiple MD trajectories, we determine the structural similarity between Y1R for the various apo, NPY, NPY/Gi, and antagonist-bound conformational states. We propose a role for W<sup>6.48</sup> in regulating Y1R binding, in which rotameric changes for W<sup>6.48</sup> influence ligand binding by favoring backbone structures in apo Y1R that are similar to those observed for the active protein. Mutation of W<sup>6.48</sup> then does not eliminate these structures but reduces their prevalence. Therefore, W<sup>6.48</sup> provides "fine-tuning" of Y1R signaling; mutation of the 6.48 position leaves Y1R active but "detuned" such that signaling is still possible, but proper functioning is inhibited by a decrease in ligand binding rate.

Journal of the American Chemical SocietyVol. 148(1)
University Medical Center (US), Leipzig University (DE)
Openalex Percentile: Top 63%
Receptor Mechanisms and Signaling
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.